Comments

Aurinia Pharmaceuticals

AUPHNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$7.00
-0.08-1.07%
Pre-Market: 6:52 PM EDT
15 minutes delayed
Aurinia Pharmaceuticals (AUPH) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Aurinia Pharmaceuticals (AUPH)?

A

There have been no specific sales or earnings guidance reported for Aurinia Pharmaceuticals in recent months.

Browse guidance and forecast on all stocks.